All included trials (N = 1446) | Trials specifically designed for older people (N = 116) | Trials not specifically designed for older people (N = 1330) | |
---|---|---|---|
Infectious | 59 (4.1%) | 2 (1.7%) | 54 (4.3%) |
Neoplasms | 142 (9.8%) | 10 (8.6%) | 132 (9.9%) |
Blood | 18 (1.2%) | 1 (0.9%) | 17 (1.3%) |
Metabolic | 135 (9.3%) | 5 (4.3%) | 130 (9.8%) |
Mental/behavioral | 112 (7.7%) | 14 (12.1%) | 98 (7.4%) |
Nervous system | 78 (5.4%) | 3 (2.6%) | 75 (5.6%0 |
Eye | 24 (1.7%) | 3 (2.6%) | 21 (1.6%) |
Ear | 3 (0.2%) | 0 (0%) | 3 (0.2%) |
Circulatory | 121 (8.4%) | 18 (15.5%) | 103 (7.7%) |
Respiratory | 57 (3.9%) | 3 (2.6%) | 54 (4.1%) |
Digestive | 63 (4.4%) | 4 (3.4%) | 59 (4.4%) |
Skin | 33 (2.3%) | 2 (1.7%) | 31 (2.3%) |
Musculoskeletal | 155 (10.7%) | 22 (19.0%) | 133 (10.0%) |
Genitourinary | 88 (6.1%) | 6 (5.2%) | 82 (6.2%) |
Pregnancy | 46 (3.2%) | 0 (0%) | 46 (3.5%) |
Perinatal | 34 (2.4%) | 0 (0%) | 34 (2.6%) |
Congenital | 9 (0.6%) | 0 (0%) | 9 (0.7%) |
Symptoms | 8 0.6%) | 0 (0%) | 8 (0.6%) |
Injury | 6 (0.4%) | 0 (0%) | 6 (0.5%) |
External | 10 (0.7%) | 0 (0%) | 10 (0.8%) |
Contact with health services | 18 (1.2%) | 2 (1.7%) | 16 (1.2%) |
Other | 227 (15.7%) | 21 (18.1%) | 206 (15.5%) |